Specialized in life-saving drugs and technologies for patients with serious and chronic diseases.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
Leading organizations
Laboratoire Aguettant
A
Specialized in essential hospital injectable drugs and ready-to-use medicines, focusing on patient safety and therapeutic solutions for hospitals.
Biotechni
B
Specialized in pharmaceutical and biotechnology industries, offering innovative solutions in industry and orthopedics.
Takeda
B
Development and commercialization of innovative medicines in various therapeutic areas, including gastrointestinal diseases, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.
Initiatives identified among leaders
Réduction des émissions de gaz à effet de serre
“Laboratoire Aguettant a réduit ses émissions de ga...” - Laboratoire AguettantMise en place d'un processus de divulgation de vulnérabilités
“Takeda met en place un processus de divulgation de...” - TakedaDiversité & Inclusion
“Biotechni sas accueille des stagiaires et offre de...” - Biotechni62% of similar organizations communicate on CSR issues
+2974 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports